nVNS for the Prevention and Treatment of Primary Headache
RecruitingNCT06277063Phase: NAStarted 2024-12-05
Summary
This study is a single-center, single-arm study. All subjects will receive the same treatment. Children and adolescents (7-20 years old) with migraine who met the inclusion criteria will be enrolled
Eligibility
Sex
ALL
Min Age
7 Years
Max Age
20 Years
Locations
Nanfang Hospital, Southern Medical UniversityGuangzhou, Guangdong, China
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06277063